Published in J Virol on June 18, 2008
The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol Biol (2008) 1.85
Extremely High Mutation Rate of HIV-1 In Vivo. PLoS Biol (2015) 1.72
Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance. PLoS Pathog (2009) 1.53
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J Mol Biol (2013) 1.39
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol (2013) 1.33
Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification. J Biol Chem (2010) 1.24
HIV infection and HERV expression: a review. Retrovirology (2012) 1.19
HIV-1 and interferons: who's interfering with whom? Nat Rev Microbiol (2015) 1.14
APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages. J Virol (2012) 1.14
The role of cytidine deaminases on innate immune responses against human viral infections. Biomed Res Int (2013) 1.11
AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res (2009) 1.09
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J Exp Med (2009) 1.07
'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era. Philos Trans R Soc Lond B Biol Sci (2013) 1.03
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif. Front Microbiol (2014) 1.00
Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins. PLoS Pathog (2008) 0.99
The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F. J Virol (2010) 0.96
APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon. PLoS Genet (2012) 0.95
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog (2014) 0.95
Powerful mutators lurking in the genome. Philos Trans R Soc Lond B Biol Sci (2009) 0.92
APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. Hum Immunol (2010) 0.92
Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution. Nat Commun (2011) 0.91
Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression. PLoS One (2011) 0.91
APOBEC3 has not left an evolutionary footprint on the HIV-1 genome. J Virol (2011) 0.90
The external domains of the HIV-1 envelope are a mutational cold spot. Nat Commun (2015) 0.89
Are viruses inhibited by APOBEC3 molecules from their host species? PLoS Pathog (2009) 0.87
A novel Bayesian method for detection of APOBEC3-mediated hypermutation and its application to zoonotic transmission of simian foamy viruses. PLoS Comput Biol (2014) 0.86
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology (2014) 0.86
APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome. Retrovirology (2012) 0.86
Mechanisms of viral mutation. Cell Mol Life Sci (2016) 0.85
Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences. J Virol (2015) 0.83
Basis for early and preferential selection of the E138K mutation in HIV-1 reverse transcriptase. Antimicrob Agents Chemother (2013) 0.82
Human endogenous retroviruses and the nervous system. Handb Clin Neurol (2014) 0.82
The decline of human endogenous retroviruses: extinction and survival. Retrovirology (2015) 0.81
The importance of becoming double-stranded: Innate immunity and the kinetic model of HIV-1 central plus strand synthesis. Virology (2013) 0.81
Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation. PLoS Pathog (2016) 0.80
Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections. J Virol (2014) 0.79
Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases. J Virol (2011) 0.79
Footprint of APOBEC3 on the genome of human retroelements. J Virol (2013) 0.79
Differential inhibition of LINE1 and LINE2 retrotransposition by vertebrate AID/APOBEC proteins. Retrovirology (2013) 0.78
Insights into the motif preference of APOBEC3 enzymes. PLoS One (2014) 0.78
Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection. Retrovirology (2015) 0.77
Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count. BMC Infect Dis (2013) 0.76
The Envelope Gene of Transmitted HIV-1 Resists a Late IFNγ-Induced Block. J Virol (2017) 0.75
The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes. PLoS Comput Biol (2017) 0.75
Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores. J Virol (2014) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature (2002) 21.53
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature (2003) 13.24
DNA deamination mediates innate immunity to retroviral infection. Cell (2003) 12.10
The Staden package, 1998. Methods Mol Biol (2000) 11.30
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science (2003) 10.79
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature (2003) 10.76
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med (2003) 9.22
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med (2003) 8.40
A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics (2005) 7.13
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics (2002) 7.10
Human LINE retrotransposons generate processed pseudogenes. Nat Genet (2000) 6.64
Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol (2004) 6.51
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol (2004) 6.26
Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science (2003) 6.20
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
HIV-1 genome nuclear import is mediated by a central DNA flap. Cell (2000) 5.87
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol (1992) 5.85
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J (2004) 5.67
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol (2003) 5.58
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol (2004) 5.35
Inhibition of hepatitis B virus replication by APOBEC3G. Science (2004) 5.15
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes. J Virol (1991) 5.03
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol (2005) 4.98
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr Biol (2004) 4.89
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol (2004) 4.76
Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science (2007) 4.60
Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol (2001) 4.53
The causes and consequences of HIV evolution. Nat Rev Genet (2004) 4.34
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J Virol (2003) 4.23
HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol (1994) 4.15
APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA. Nat Struct Mol Biol (2006) 4.00
Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med (1998) 3.84
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J Mol Biol (2004) 3.59
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature (2005) 3.53
A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol (1992) 3.39
APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem (2006) 3.30
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol (2006) 3.27
Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol (2005) 3.26
Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci U S A (2004) 3.19
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J Biol Chem (2006) 3.03
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol (2007) 2.95
APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem (2006) 2.86
APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci (2007) 2.80
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol (2005) 2.61
Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res (2006) 2.55
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 2.54
Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog (2007) 2.52
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res (2007) 2.49
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J Virol (2007) 2.47
Discovery and analysis of the first endogenous lentivirus. Proc Natl Acad Sci U S A (2007) 2.43
Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet (2007) 2.33
Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. J Virol (2006) 2.32
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res (2004) 2.28
Human-specific integrations of the HERV-K endogenous retrovirus family. J Virol (1998) 2.25
Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol (2005) 2.21
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J Virol (2008) 2.21
Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase. J Virol (2005) 2.04
Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1. J Virol (2007) 2.03
Rapid evolution of primate antiviral enzyme APOBEC3G. Hum Mol Genet (2004) 2.03
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc Natl Acad Sci U S A (2005) 2.00
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology (2006) 1.94
Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J Virol (2002) 1.91
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol (1995) 1.91
A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol (1991) 1.90
APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. J Biol Chem (2007) 1.87
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation. J Virol (2006) 1.75
The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA. J Virol (2007) 1.74
Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J Gen Virol (2002) 1.72
Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication. Nucleic Acids Res (2006) 1.67
Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res (2006) 1.53
Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus. J Virol (1995) 1.47
Gradual adaptation of HIV to human host populations: good or bad news? Nat Med (2003) 1.46
The evolutionary dynamics of endogenous retroviruses. Trends Microbiol (2005) 1.41
Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F. Virology (2007) 1.35
Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. Virology (1985) 1.27
First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection. Virology (2003) 1.12
Identification of a central DNA flap in feline immunodeficiency virus. J Virol (2001) 1.10
Identification and characterization of an exogenous retrovirus from atlantic salmon swim bladder sarcomas. J Virol (2006) 1.05
Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B. J Virol (2006) 1.01
Adaptation and immunity. PLoS Biol (2004) 1.01
Sequence and transcriptional analyses of the fish retroviruses walleye epidermal hyperplasia virus types 1 and 2: evidence for a gene duplication. J Virol (1999) 1.00
Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection. AIDS Res Hum Retroviruses (2003) 0.98
Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome. Biochemistry (1999) 0.94
DNA curvature controls termination of plus strand DNA synthesis at the centre of HIV-1 genome. J Mol Biol (1997) 0.94
HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV. AIDS Res Hum Retroviruses (2007) 0.88
BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13
Relaxed phylogenetics and dating with confidence. PLoS Biol (2006) 37.68
Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol (2012) 32.00
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
Estimating the rate of intersubtype recombination in early HIV-1 group M strains. J Virol (2012) 12.78
DNA deamination mediates innate immunity to retroviral infection. Cell (2003) 12.10
Bayesian phylogeography finds its roots. PLoS Comput Biol (2009) 10.99
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 10.03
Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol (2005) 8.42
Rise and fall of the Beringian steppe bison. Science (2004) 7.91
Many-core algorithms for statistical phylogenetics. Bioinformatics (2009) 6.70
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med (2009) 6.22
BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics. Syst Biol (2011) 5.40
Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol (2002) 5.24
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis (2013) 4.87
Acute HIV-1 Infection. N Engl J Med (2011) 4.84
Phylogeography takes a relaxed random walk in continuous space and time. Mol Biol Evol (2010) 4.82
Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med (2008) 4.76
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med (2012) 4.74
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol (2003) 4.68
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol (2007) 4.64
Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet (2009) 4.56
The molecular population genetics of HIV-1 group O. Genetics (2004) 4.53
SPREAD: spatial phylogenetic reconstruction of evolutionary dynamics. Bioinformatics (2011) 4.41
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology (2010) 4.18
Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol Biol Evol (2012) 4.16
Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty. Infect Genet Evol (2007) 4.11
Viral mutation rates. J Virol (2010) 3.87
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis (2013) 3.35
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol (2004) 3.20
Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci U S A (2004) 3.19
A structural basis for immunodominant human T cell receptor recognition. Nat Immunol (2003) 3.15
Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.10
Characterization of CD4(+) CTLs ex vivo. J Immunol (2002) 3.10
Accommodating the effect of ancient DNA damage on inferences of demographic histories. Mol Biol Evol (2008) 3.07
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J Biol Chem (2006) 3.03
Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One (2010) 3.02
Inferring confidence sets of possibly misspecified gene trees. Proc Biol Sci (2002) 2.98
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97
Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology (2010) 2.90
The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A (2007) 2.89
APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci (2007) 2.80
A Bayesian phylogenetic method to estimate unknown sequence ages. Mol Biol Evol (2010) 2.73
Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS One (2007) 2.61
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature (2006) 2.61
Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol (2008) 2.59
GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol (2003) 2.52
Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol (2006) 2.50
Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio (2014) 2.50
Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution. Mol Biol Evol (2007) 2.34
Ancient hybridization and an Irish origin for the modern polar bear matriline. Curr Biol (2011) 2.33
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol (2005) 2.33
HIV evolutionary dynamics within and among hosts. AIDS Rev (2006) 2.32
The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity (2008) 2.31
A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc Natl Acad Sci U S A (2008) 2.28
Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol (2007) 2.25
Inference of viral evolutionary rates from molecular sequences. Adv Parasitol (2003) 2.23
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med (2005) 2.18
Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol (2005) 2.12
Inferring the rate and time-scale of dengue virus evolution. Mol Biol Evol (2003) 2.11
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol (2006) 2.11
Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog (2009) 2.10
Temporally structured metapopulation dynamics and persistence of influenza A H3N2 virus in humans. Proc Natl Acad Sci U S A (2011) 2.06
A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res (2009) 2.06
Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol Biol Evol (2012) 2.02
Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med (2003) 2.01
T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med (2004) 1.99
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS (2002) 1.92
Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog (2010) 1.88
Endemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmission. PLoS Pathog (2011) 1.87
Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest (2003) 1.85
Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2012) 1.83
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol (2009) 1.83
Phylodynamics and human-mediated dispersal of a zoonotic virus. PLoS Pathog (2010) 1.83
Evolutionary genomics of Staphylococcus aureus reveals insights into the origin and molecular basis of ruminant host adaptation. Genome Biol Evol (2010) 1.81
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol (2004) 1.80
Using time-structured data to estimate evolutionary rates of double-stranded DNA viruses. Mol Biol Evol (2010) 1.80
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol (2004) 1.78
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. J Virol (2007) 1.74
Quantifying adaptive evolution in the Drosophila immune system. PLoS Genet (2009) 1.74
CCL3L1 and HIV/AIDS susceptibility. Nat Med (2009) 1.73
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A (2010) 1.71
Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools. Infect Genet Evol (2013) 1.69
Spatial dynamics of human-origin H1 influenza A virus in North American swine. PLoS Pathog (2011) 1.68
Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol (2011) 1.66
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine (2010) 1.65
Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions. Proc Natl Acad Sci U S A (2010) 1.64